The U.S. 2nd Circuit Court of Appeals recently denied insulin drugmakers' petition for rehearing in a 340B antitrust case.

Appeals Court Rejects Insulin Drugmakers’ Rehearing Request, Allows 340B Providers’ Antitrust Case to Return to Lower Court

December 11, 2025 Shannon Young, Associate Editor/Senior Writer 340B Report Views

A New York City federal appeals court recently denied four major insulin manufacturers’ request that judges reconsider an August decision [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!